Selective Inhibition of Membrane Type 1 Matrix Metalloproteinase Abrogates Progression of Experimental Inflammatory Arthritis: Synergy With Tumor Necrosis Factor Blockade
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Selective Inhibition of Membrane Type 1 Matrix Metalloproteinase Abrogates Progression of Experimental Inflammatory Arthritis: Synergy With Tumor Necrosis Factor Blockade
Authors
Keywords
-
Journal
Arthritis & Rheumatology
Volume 68, Issue 2, Pages 521-531
Publisher
Wiley
Online
2015-08-28
DOI
10.1002/art.39414
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The global burden of rheumatoid arthritis: estimates from the Global Burden of Disease 2010 study
- (2014) Marita Cross et al. ANNALS OF THE RHEUMATIC DISEASES
- Novel small molecule therapeutics in rheumatoid arthritis
- (2013) V. Kelly et al. RHEUMATOLOGY
- Incomplete response of inflammatory arthritis to TNFα blockade is associated with the Th17 pathway
- (2012) Saba Alzabin et al. ANNALS OF THE RHEUMATIC DISEASES
- Site-specific cellular functions of MT1-MMP
- (2012) Agnieszka Koziol et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- Remission and radiographic outcome in rheumatoid arthritis: application of the 2011 ACR/EULAR remission criteria in an observational cohort
- (2011) Siri Lillegraven et al. ANNALS OF THE RHEUMATIC DISEASES
- Increasing levels of circulating Th17 cells and interleukin-17 in rheumatoid arthritis patients with an inadequate response to anti-TNF-α therapy
- (2011) Der-Yuan Chen et al. ARTHRITIS RESEARCH & THERAPY
- Membrane-Type I Matrix Metalloproteinase-Dependent Regulation of Rheumatoid Arthritis Synoviocyte Function
- (2010) F. Sabeh et al. JOURNAL OF IMMUNOLOGY
- Rheumatoid arthritis
- (2010) David L Scott et al. LANCET
- The effectiveness of anti-TNF- therapies when used sequentially in rheumatoid arthritis patients: a systematic review and meta-analysis
- (2010) S. Lloyd et al. RHEUMATOLOGY
- Increased IL-17 production by peripheral T helper cells after tumour necrosis factor blockade in rheumatoid arthritis is accompanied by inhibition of migration-associated chemokine receptor expression
- (2010) N. E. Aerts et al. RHEUMATOLOGY
- Clinical efficacy and safety of abatacept in methotrexate-naive patients with early rheumatoid arthritis and poor prognostic factors
- (2009) R Westhovens et al. ANNALS OF THE RHEUMATIC DISEASES
- Membrane type 1 matrix metalloproteinase is a crucial promoter of synovial invasion in human rheumatoid arthritis
- (2009) Mary-Clare Miller et al. ARTHRITIS AND RHEUMATISM
- Selective Inhibition of Matrix Metalloproteinase-14 Blocks Tumor Growth, Invasion, and Angiogenesis
- (2009) Laetitia Devy et al. CANCER RESEARCH
- Synovial fibroblasts spread rheumatoid arthritis to unaffected joints
- (2009) Stephanie Lefèvre et al. NATURE MEDICINE
- The role and therapeutic implications of fibroblast-like synoviocytes in inflammation and cartilage erosion in rheumatoid arthritis
- (2008) Erika H. Noss et al. IMMUNOLOGICAL REVIEWS
- Blockade of tumor necrosis factor in collagen-induced arthritis reveals a novel immunoregulatory pathway for Th1 and Th17 cells
- (2008) Clare A. Notley et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Cartilage degradation is fully reversible in the presence of aggrecanase but not matrix metalloproteinase activity
- (2008) Morten A Karsdal et al. ARTHRITIS RESEARCH & THERAPY
- Reappraising metalloproteinases in rheumatoid arthritis and osteoarthritis: destruction or repair?
- (2008) Gillian Murphy et al. Nature clinical practice. Rheumatology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now